Brief: Spruce Biosciences, Inc. Q2 basic EPS USD -0.32
14/08/2023 21:47
Aug 14 (Reuters) - Spruce Biosciences, Inc. Q2 basic EPS USD -0.32. * Q2 net income USD -12.824 million * Q2 income from operations USD -13.972 million * Q2 operating expenses USD 16.137 million
Recent news on Spruce Biosciences
See all newsSpruce Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Spruce Biosciences Q2 net loss widens on higher expenses
Spruce Biosciences, Inc. expected to post a loss of $5.80 a share - Earnings Preview
Brief: Spruce Biosciences Appoints Adrian Quartel, M.D., Ffpm, As Chief Medical Officer
Brief: Spruce Biosciences Announces Data Presentation At The 18Th International MPS Symposium